2Suppliers
7Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Quanterix Corporation (QTRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

13Total relationships
3Distinct source URLs
7High confidence
0.808Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Quanterix Corporation Suppliers

TickerNameConfidenceEvidence
LLY Eli Lilly and Company 72% Reciprocal relationship from LLY graph: Reciprocal relationship from QTRX graph: accounted for greater than % of the Company’s total revenue. For the year ended December 31, 2023, customer of approxi…
LLY Eli Lilly and Company 72% accounted for greater than % of the Company’s total revenue. For the year ended December 31, 2023, customer of approximately $ million revenue accounted for greater than % of the Company’s total reve…

Quanterix Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $209,164 across 5 awards. 75N93021P00634 QUANTERIX SP-X ULTRA-SENSITIVE BIOMARKER DETECTION SYSTEM; 75N95024P00082 MAINTENANCE SERVICE…
SIMOA SIMOA 92% All of the Company's collaboration and license revenue was generated by Simoa technology.
SPATIAL-BIOLOGY SPATIAL-BIOLOGY 92% All of the Company's collaboration and license revenue was generated by Simoa technology.
LLY Eli Lilly and Company 72% Reciprocal relationship from LLY graph: Reciprocal relationship from QTRX graph: Reciprocal relationship from LLY graph: Reciprocal relationship from QTRX graph: Reciprocal relationship from LLY grap…
LLY Eli Lilly and Company 72% nary shares of UltraDx with a deemed fair value of $ million. The issuance of the shares was contingent on UltraDx completing a preferred share financing under the terms and conditions in the UltraDx…
AKOYA-BIOSCIENCES-INC AKOYA-BIOSCIENCES-INC 62% therapies and diagnostics and has the potential to identify early-stage disease markers before symptoms appear. Our instruments are designed to be used either with assays fully developed by us, inclu…
PERKIN-ELMER-INC PERKIN-ELMER-INC 62% ,027 $ 3,946 $ 25,479 $ 11,731 $ 5,211 $ 3,797 $ 20,739 Service and other revenue: Research services $ 3,861 $ 245 $ 247 $ 4,353 $ 5,006 $ 329 $ 266 $ 5,601 Service-type warranties 1,669 956 282 2,90…

Quanterix Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
QTRX-DEBT Debt stack $3.9M 90% Market cache reports total debt of $3.9M.
QTRX-DEBT-12018 Warrants outstanding: 29000 90% xbrl warrant detail from xbrl 2017-12-31.
QTRX-DEBT-12019 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-12-31.

Quanterix Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Quanterix Corporation.

Quanterix Corporation Ownership

HolderNameConfidenceEvidence
QTRX-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 130 tracked holders.

Quanterix Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
LLY Eli Lilly and Company 100.00 1 ['customer', 'supplier']
SIMOA SIMOA 63.48 1 ['receiving']
DAWN Day One Biopharmaceuticals Inc 50.00 2
BIOA BioAge Labs, Inc. 50.00 2
FHTX Foghorn Therapeutics Inc. 50.00 2
DSGN Design Therapeutics, Inc. 50.00 2
EDSA Edesa Biotech, Inc. 50.00 2
ALNY Alnylam Pharmaceuticals, Inc. 50.00 2
VEEV Veeva Systems Inc. 50.00 2
BCYC Bicycle Therapeutics plc 50.00 2
LGND Ligand Pharmaceuticals Incorporated 50.00 2
AMPH Amphastar Pharmaceuticals, Inc. 50.00 2
NVO Novo Nordisk A/S 50.00 2
GYRE Gyre Therapeutics, Inc. 50.00 2
SDGR Schrödinger, Inc. 50.00 2
AKTS Aktis Oncology, Inc. 50.00 2
ELAN Elanco Animal Health Incorporated 50.00 2
CRNX Crinetics Pharmaceuticals, Inc. 50.00 2
CAH Cardinal Health, Inc. 50.00 2
AXSM Axsome Therapeutics, Inc. 50.00 2
🔐
QTRX
Unlock QTRX Supply Chain Data
Verified relationships include:
LLYEli Lilly and CompanySupplier72%
LLYEli Lilly and CompanySupplier72%
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICESUSGOV-DEPARTMENT-OF-HEALT…Customer95%
SIMOASIMOACustomer92%
+9 more relationships locked
Subscribe — View plans →